Clough Capital Partners’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-24,850
Closed -$318K 129
2025
Q2
$318K Buy
+24,850
New +$306K 0.03% 116
2025
Q1
Sell
-38,519
Closed -$505K 124
2024
Q4
$505K Hold
38,519
0.06% 104
2024
Q3
$581K Sell
38,519
-36,110
-48% -$546K 0.06% 110
2024
Q2
$1.06M Sell
74,629
-45,011
-38% -$609K 0.12% 85
2024
Q1
$1.63M Sell
119,640
-255,770
-68% -$3.54M 0.18% 74
2023
Q4
$5.05M Buy
375,410
+244,960
+188% +$3.01M 0.56% 51
2023
Q3
$1.63M Buy
+130,450
New +$1.72M 0.17% 105
2020
Q4
Sell
-58,926
Closed -$1.04M 145
2020
Q3
$1.04M Buy
58,926
+19,200
+48% +$344K 0.07% 90
2020
Q2
$713K Buy
+39,726
New +$681K 0.07% 109
2017
Q2
Sell
-48,545
Closed -$825K 150
2017
Q1
$825K Hold
48,545
0.05% 109
2016
Q4
$825K Buy
+48,545
New +$852K 0.05% 124
2016
Q3
Sell
-30,922
Closed -$532K 196
2016
Q2
$532K Buy
+30,922
New +$571K 0.03% 157
2015
Q4
Sell
-8,900
Closed -$200K 211
2015
Q3
$200K Buy
+8,900
New +$249K 0.01% 170

Other funds holding HQL

Clough Capital Partners's HQL Position: Q3 2025 in Review

Clough Capital Partners sold out of abrdn Life Sciences Investors (HQL) in Q3 2025, closing a stake of 24,850 shares — an estimated $318K sold.

Clough Capital Partners first reported a position in HQL in Q3 2015 and held it in 13 quarters. The position peaked at $5.05M in Q4 2023. 83 funds tracked by Wall St. Rank hold HQL as of Q3 2025.

  • Clough Capital Partners reported no remaining abrdn Life Sciences Investors position as of Q3 2025 after selling out during the quarter.
  • Clough Capital Partners sold 24,850 abrdn Life Sciences Investors shares in Q3 2025, an estimated $318K.
  • Clough Capital Partners first reported a position in abrdn Life Sciences Investors in Q3 2015 and held it in 13 quarters.
  • Clough Capital Partners's abrdn Life Sciences Investors position peaked at $5.05M in Q4 2023.
  • 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2025.

Based on Clough Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.